Sprucegrove Investment Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.67M | Sell |
13,310
-800
| -6% | -$100K | 0.14% | 32 |
|
|
2025
Q1 | $1.93M | Sell |
14,110
-83,745
| -86% | -$11.5M | 0.21% | 30 |
|
|
2024
Q4 | $15M | Hold |
97,855
| – | – | 1.07% | 22 |
|
|
2024
Q3 | $19M | Sell |
97,855
-200
| -0.2% | -$38.8K | 1.06% | 21 |
|
|
2024
Q2 | $22.7M | Buy |
98,055
+1,200
| +1% | +$278K | 1.18% | 15 |
|
|
2024
Q1 | $20.9M | Buy |
96,855
+34,100
| +54% | +$7.35M | 0.84% | 21 |
|
|
2023
Q4 | $16.2M | Buy |
62,755
+800
| +1% | +$207K | 0.7% | 16 |
|
|
2023
Q3 | $15.9M | Buy |
61,955
+1,943
| +3% | +$499K | 1% | 13 |
|
|
2023
Q2 | $17.1M | Sell |
60,012
-11,388
| -16% | -$3.24M | 0.89% | 14 |
|
|
2023
Q1 | $19.9M | Buy |
71,400
+2,700
| +4% | +$751K | 1.08% | 13 |
|
|
2022
Q4 | $19M | Sell |
68,700
-27,800
| -29% | -$7.7M | 1.05% | 16 |
|
|
2022
Q3 | $25.8M | Sell |
96,500
-73,000
| -43% | -$19.5M | 1.48% | 11 |
|
|
2022
Q2 | $34.6M | Sell |
169,500
-94,700
| -36% | -$19.3M | 1.72% | 16 |
|
|
2022
Q1 | $55.6M | Sell |
264,200
-59,300
| -18% | -$12.5M | 1.79% | 21 |
|
|
2021
Q4 | $77.6M | Buy |
323,500
+89,500
| +38% | +$21.5M | 1.96% | 21 |
|
|
2021
Q3 | $66.2M | Buy |
234,000
+33,600
| +17% | +$9.51M | 1.63% | 22 |
|
|
2021
Q2 | $69.4M | Buy |
200,400
+96,900
| +94% | +$33.6M | 1.64% | 21 |
|
|
2021
Q1 | $29M | Buy |
+103,500
| New | +$29M | 0.71% | 32 |
|